Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.89Enterprise Value over EBITDA
VS
Market
Sector
Industry
History
$ 5.53Close
$ 4.18 - $ 7.23 52-Week Range
Ticker Information
Ticker
ABEOCompany Name
ABEONA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABEONA THERAPEUTICS INC - Enterprise Value over EBITDA Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABEO - EV/EBITDA Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
|---|---|---|---|
| 6/30/2025 | $ 79.97M | $ 230.95M | 2.89 |
| 3/31/2025 | $ -36.93M | $ 303.9M | 0 |
| 12/31/2024 | $ -56.62M | $ 248.82M | 0 |
| 9/30/2024 | $ -64.94M | $ 265.7M | 0 |
| 6/30/2024 | $ -47.48M | $ 202.81M | 0 |
| 3/31/2024 | $ -72.36M | $ 199.26M | 0 |
| 12/31/2023 | $ -50.57M | $ 181.8M | 0 |
| 9/30/2023 | $ -34.75M | $ 112.12M | 0 |
| 6/30/2023 | $ -32.01M | $ 73.18M | 0 |
| 3/31/2023 | $ -22.91M | $ 58.07M | 0 |
Key Performance Insights, Last 5 Years
- ABEONA THERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
- Over the past 5 years, ABEONA THERAPEUTICS INC's average EV/EBITDA has been 2.89.
- The median EV/EBITDA for ABEONA THERAPEUTICS INC during this period was 2.89
- ABEONA THERAPEUTICS INC reached its highest EV/EBITDA over the past 5 years at 2.89.
- The lowest EV/EBITDA recorded by ABEONA THERAPEUTICS INC in the same timeframe 2.89
Similar metrics to EV/EBITDA:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) - [Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
Definition of Enterprise Value over EBITDA
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].EV / EBITDA
(=) EV/EBITDA EV/EBITDA for ABEONA THERAPEUTICS INC is calculated as follows: EV [ $ 105.98M ] / EBITDA [ $ -74.28M ]
(=) EV/EBITDA [ 0 ] ABEO - Enterprise Value over EBITDA, Last 5 years
2.89
Minimum
Jun 30, 2025
2.89
Maximum
Jun 30, 2025
2.89
Average
2.89
Median
EV/EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.49 with a standard deviation of 7.66.
The following table provides additional summary stats:
EV/EBITDA in the Market:
| filtered constituents | 2.44K |
|---|---|
| min | 0.01 |
| max | 40.82 |
| average | 13.49 |
| median | 11.75 |
| std | 7.66 |